ARC-sparX Platform Technology & Novel BCMA-Targeting Binding Domain for the Treatment of Patients with RRMM

Time: 11:30 am
day: Day Two

Details:

  • Exploring preclinical rationale, clinical trial results, and the next steps for CARTddBCMA as well as the next generation ARCsparX platform

Speakers: